血清胱抑素C、同型半胱氨酸及尿微量白蛋白在高血压患者肾损害早期评估中的应用价值

doi:10.3969/j.issn.1000-8535.2024.08.008

摘要/Abstract

摘要： 目的探讨血清胱抑素C（SCys-C）、同型半胱氨酸（Hcy）及尿微量白蛋白（UmAlb）在高血压患者肾损害早期评估中的应用价值。方法选择2022年9月—2023年9月期间福建中医药大学附属第三人民医院接收的150例高血压患者作为观察组,另选择健康体检者150例为对照组,测定肾小球滤过率（GFR）、SCys-C、Hcy、UmAlb,比较不同血压程度及对照组的各指标水平,比较观察组各指标检测阳性率及诊断符合率,依据GFR值评估肾损害程度,比较不同肾损害程度患者的SCys-C、Hcy、UmAlb水平。结果高血压2级、高血压3级患者SCys-C、Hcy、UmAlb水平高于高血压1级患者（t=5.255、10.976、21.578,P<0.05;t=7.378、18.012、23.708,P<0.05）及对照组患者（t=8.308、19.675、31.891,P<0.05;t=10.661、31.511、21.578,P<0.05）,高血压3级患者高于高血压2级患者（t=2.776、12.725、7.779,P<0.05）。观察组肾损害患者SCys-C、Hcy、UmAlb的阳性率79.41%、73.53%、83.82%高于无肾损害患者的阳性率6.10%、4.88%、6.10%（χ²=83.733、76.040、92.613,P<0.05）。观察组中重度肾损害、轻度肾损害患者的SCys-C、Hcy、UmAlb水平高于无损害患者（t=7.567、24.214、30.836,P<0.05;t=5.783、16.054、25.164,P<0.05）,中重度肾损害高于轻度肾损害患者（t=2.685、7.179、9.561,P<0.05）。结论高血压分级越高患者的SCys-C、Hcy、UmAlb水平越高,各指标联合检测的阳性率高,而且SCys-C、Hcy、UmAlb水平越高,肾损害程度越严重。

关键词: 高血压, 肾损害, 血清胱抑素C, 同型半胱氨酸, 尿微量白蛋白

Abstract: Objective To explore the application value of serum cystatin C（SCys-C）,homocysteine（Hcy） and urinary microalbumin（UmAlb）in early assessment of renal damage in hypertensive patients．Methods A total of 150 hypertensive patients admitted to the Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine from September 2022 to September 2023 were selected as the observation group,and 150 healthy individuals were selected as the control group．Glomerular filtration rate（GFR）,serum cystatin C（SCys-C）,homocysteine（Hcy）,and UmAlb were measured,and the levels of various indicators in different blood pressure levels and the control group were compared．The positive rate and diagnostic accuracy of each indicator in the observation group were compared,and the degree of renal damage was evaluated based on GFR values．The levels of SCys-C,Hcy and UmAlb in patients with different degrees of renal damage were compared．Results The levels of SCys-C,Hcy and UmAlb in patients with grade 2 and grade 3 hypertension were significantly higher than those in patients with grade 1 hypertension（t=5.255,10.976,21.578,P<0.05;t=7.378,18.012,23.708,P<0.05）,as well as in the control group（t=8.308,19.675,31.891,P<0.05;t=10.661,31.511,21.578,P<0.05）,patients with grade 3 hypertension were significantly higher than those with grade 2 hypertension（t=2.776,12.725,7.779,P<0.05）．The positive rates of SCys-C,Hcy and UmAlb in patients with renal injury in the observation group were 79.41%,73.53% and 83.82%,which were significantly higher than the positive rates of 6.10%,4.88% and 6.10% in patients without renal injury（χ²=83.733,76.040,92.613,P<0.05）．The levels of SCys-C,Hcy and UmAlb in patients with severe and mild kidney damage in the observation group were significantly higher than those in patients without damage（t=7.567,24.214,30.836,P<0.05;t=5.783,16.054,25.164,P<0.05）,patients with moderate to severe kidney damage were significantly higher than those with mild kidney damage（t=2.685,7.179,9.561,P<0.05）．Conclusions The higher the grading of hypertension,the higher the levels of SCys-C,Hcy and UmAlb in patients,and the higher the positive rate of combined detection of various indicators．Moreover,the higher the levels of SCys-C,Hcy and UmAlb,the more severe the renal damage．

Key words: hypertension, kidney damage, serum cystatin C, homocysteine, urinary microalbumin

郑晓仙, 龚启斌, 魏丽华. 血清胱抑素C、同型半胱氨酸及尿微量白蛋白在高血压患者肾损害早期评估中的应用价值[J]. 广州医药, 2024, 55(8): 875-880.

ZHENG Xiaoxian, GONG Qibin, WEI Lihua. The application value of serum cystatin C,homocysteine and urinary microalbumin in early assessment of renal damage in hypertensive patients[J]. Guangzhou Medical Journal, 2024, 55(8): 875-880.

参考文献

[1] 覃显波,黄晓雅,林金环.H型高血压患者肾损害危险因素的多因素Logistic回归分析[J].内科,2020,15(1):39-41,44.
[2] 陈加梅,刘融,徐伟伟,等.尿微量白蛋白/肌酐联合血清Cys-C、Hcy对妊娠期高血压患者肾功能损害的预测价值分析[J].中国卫生检验杂志,2023,33(7):827-830.
[3] 刘荣. 尿微量白蛋白检测对老年高血压早期肾损害的临床意义[J].中国医药指南,2020,18(26):91-92.
[4] 寇天,郝振伟,陈曦.尿微量白蛋白/肌酐比值、血清肌酐和血清胱抑素C对老年高血压患者早期肾损害的诊断价值研究[J].医学信息,2023,36(2):103-106.
[5] 中国高血压防治指南修订委员会,高血压联盟(中国,中华医学会心血管病学分会中国医师协会高血压专业委员会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.
[6] 余蓓蕾,姜玲,李喆,等.肾小球滤过率对急慢性肾脏病患者溶质及电解质肾脏排泄分数的影响[J].肾脏病与透析肾移植杂志,2023,32(1):1-7.
[7] 杜卫军,李相友.SLE肾损害患者白蛋白肌酐比值、GFR水平情况及其同病变程度的关系性分析[J].临床与病理杂志,2015(6):942-945.
[8] 虞鸣娟,杨凯,叶诗雨.尿微量白蛋白、血清胱抑素C和血清同型半胱氨酸联合检测诊断高血压肾病的诊断价值[J].系统医学,2023,8(10):30-33.
[9] 孟星,杨凯,胡振华.高血压肾脏损害患者血清脂联素、胱抑素C和同型半胱氨酸联合检测的临床意义[J].系统医学,2023,8(2):62-65.
[10] 甘超华,刘洁华.血清β2-微球蛋白和血清胱抑素C水平在高血压肾病早期肾损害中应用[J].数理医药学杂志,2020,33(6):891-892.
[11] 张丹,李宏飞,闫梅,等.原发性高血压患者血清胱抑素C、同型半胱氨酸与靶器官损害的关系[J].岭南心血管病杂志,2022,28(6):540-544.
[12] 陈志祥. 尿微量白蛋白与血清胱抑素C联合检测在诊断高血压肾损害中的应用价值[J].当代医药论丛,2021,19(22):143-144.
[13] 汪辉. 血清β2-微球蛋白和血清胱抑素C 检测对早期高血压肾病的诊断价值[J].中国社区医师,2022,38(14):97-99.
[14] 胡红梅,杨小燕,马伟科,等.血清Cystatin C对高血压患者早期肾损害诊断价值的研究[J].宁夏医学杂志,2020,42(12):1118-1120.
[15] 罗长志,张丽钦.凝血四项指标与血清CysC水平检测在高血压肾损伤早期预测中的应用[J].心血管病防治知识,2022,12(28):15-17.
[16] 吴小娅,戴康伟,曾瑞颖,等.同型半胱氨酸联合β2微球蛋白对H型高血压患者肾损害的早期预测价值[J].中国卫生检验杂志,2022,32(10):1228-1231.
[17] 陈添儒,李莹,王建刚,等.慢性肾脏病患者胱抑素C、同型半胱氨酸与动脉硬化指标的相关性[J].中南大学学报(医学版),2021,46(12):1338-1345.
[18] 邓心悦,蒋磊英,沈爱玲.同型半胱氨酸、载脂蛋白B/载脂蛋白A比值及尿微量白蛋白/肌酐比值的变化与高血压早期肾损伤的关系研究[J].河北医药,2022,44(16):2473-2476.
[19] 王锋,巫大伟,陈亚新.多种指标联合检测对老年高血压早期肾损害的诊断价值[J].中国老年学杂志,2022,42(16):3991-3993.
[20] 朱素娟. 血清Cys C联合Hcy检测在评估高血压患者早期肾损害中的临床意义[J].河南医学研究,2019,28(5):906-907.
[21] 朱怡,秦艳,何珏.血清miR-15b、miR-29a和CysC在妊娠高血压疾病肾脏损害中的临床诊断价值[J].疑难病杂志,2020,19(2):170-174,179.
[22] 邢莉,申虎威.早期肾损伤标志物对老年高血压糖尿病肾损害的诊断价值[J].中国药物与临床,2020,20(20):3356-3358.
[23] 王兴华,杨洪娟,胡秀红,等.血清胱抑素C联合同型半胱氨酸检测对高血压早期肾病的临床意义[J].中国临床医生杂志,2021,49(1):63-65.
[24] 窦娟,姚武位,徐新献,等.血尿素氮、血肌酐、血清胱抑素C及24h动态脉压对老年高血压患者早期肾损害的临床评价[J].现代医药卫生,2019,35(22):3462-3464.
[25] 杨秀莲,张成磊,岳晋巍,等.原发性高血压早期肾损害与血清25-羟维生素D和同型半胱氨酸相关性分析[J].宁夏医科大学学报,2019,41(4):359-363.
[26] 许怡文. 糖尿病肾病患者肾功能恶化进展的危险因素[J].广州医药,2021,52(5):40-43,72.
[27] 贾晓卉,王珍,黄捷.血清胱抑素C、尿微量白蛋白和β 2-微球蛋白联合检测诊断妊娠高血压综合征患者早期肾损害的价值[J].国际移植与血液净化杂志,2021,19(2):29-31,34.
[28] 林超师,何培燕,林南生.高血压早期肾损害患者血清胱抑素C尿β2-微球蛋白全血超敏C反应蛋白水平变化的临床意义[J].实用医技杂志,2020,27(9):1171-1173.